← Evidence map

ArticleFrontiers in immunology2023

Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against

Ti Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37744341